Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: Safety and feasibility study Academic Article uri icon

Overview

MeSH Major

  • Thrombectomy
  • Thrombolytic Therapy
  • Venous Thrombosis

abstract

  • Addition of lytic agent to PMT facilitates thrombus extraction, decreases overall interventional treatment time, and improves patient outcomes. In addition, definitive management of underlying anatomic lesions can be performed in the same setting. Further outcome measures are necessary to study the long-term efficacy of this treatment method on preservation of valve function, reduction of chronic venous insufficiency, and improved quality of life.

publication date

  • November 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jvs.2004.08.025

PubMed ID

  • 15557912

Additional Document Info

start page

  • 965

end page

  • 70

volume

  • 40

number

  • 5